Skip to content

Manufacturing of Drynaria Rhizome gel for its application in the treatment of gum disease

Formulation and Evaluation of Drynaria Rhizome In-situ gel as Local Drug Deleivry system for the treatment of Periodontal Diseases. - NIL

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/066873
Enrollment
40
Registered
2024-05-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K053- Chronic periodontitis

Interventions

None listed

Sponsors

Dr Kaushal Pati Tripathi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients diagnosed as having chronic periodontitis with periodontal pockets of =3mm 2.Age group between 25-45years. 3.Patients with good general health, without any history of systemic disease or under medication.

Exclusion criteria

Exclusion criteria: 1.Patients showing unacceptable oral hygiene during pre- surgical (Phase I) period. 2.Smokers, pregnant women, and lactating mothers.

Design outcomes

Primary

MeasureTime frame
Reduction in Probing pocket depth (usingUNC-15probe with occlusal stent) and Clinical attachment Improvemnt in Clinical attachment level(using UNC-15probe with occlusal stent).Timepoint: 1, 3 and 4 weeks

Secondary

MeasureTime frame
Improvement in Plaque Index(Silness and Loe, 1964) Gingival Index(Loe and Silness,1963)Timepoint: 1, 3 and 4 weeks

Countries

India

Contacts

Public ContactKaushal Pati Tripathi

Department of Periodontics, FODS

jeevankaushal03@gmail.com9098925613

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026